Added to YB: 2025-12-12
Pitch date: 2025-10-20
CYRX [bullish]
Cryoport, Inc.
-12.61%
current return
Author Info
No bio for this author
Company Info
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Market Cap
$506.9M
Pitch Price
$10.55
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.85
P/E
-4.16
EV/Sales
2.23
Sector
Life Sciences Tools and Services
Category
growth
Cryoport, Inc. - $CYRX
CYRX: Dominant 70% share in C> logistics (424 registrational trials, 18 commercial drugs). Commercial rev could grow 20x from $26M to $500M by 2035 as pipeline matures. Sold worst asset CRYOPDP for $195M (2.7x cost), FDA loosened REMS requirements, drugs moving to earlier treatment lines. Trading 4.5x potential $100M EBITDA vs peers at 50-60x.
Read full article (6 min)